2016
DOI: 10.3109/02656736.2016.1157216
|View full text |Cite
|
Sign up to set email alerts
|

Improving efficacy of hyperthermia in oncology by exploiting biological mechanisms

Abstract: It has long been established that hyperthermia increases the therapeutic benefit of radiation and chemotherapy in cancer treatment. During the last few years there have been substantial technical improvements in the sources used to apply and measure heat, which greatly increases enthusiasm for the clinical use of hyperthermia. These advances are converging with a better understanding of the physiological and molecular effects of hyperthermia. Therefore, we are now at a juncture where the parameters that will i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
85
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 102 publications
(88 citation statements)
references
References 103 publications
0
85
0
1
Order By: Relevance
“…While radiosensitisation by increased perfusion and reoxygenation [43,44] can be observed already at 39 C, the effect increases substantially with increasing temperature with more direct radiosensitisation due to the inhibition of DNA damage repair machinery [45][46][47]. Also chemosensitisation starts at relatively low temperatures for many chemotherapy compounds, including drugs frequently used in pancreatic cancer, such as gemcitabine and fluorouracil [48][49][50][51].…”
Section: Temperature Measurementsmentioning
confidence: 99%
“…While radiosensitisation by increased perfusion and reoxygenation [43,44] can be observed already at 39 C, the effect increases substantially with increasing temperature with more direct radiosensitisation due to the inhibition of DNA damage repair machinery [45][46][47]. Also chemosensitisation starts at relatively low temperatures for many chemotherapy compounds, including drugs frequently used in pancreatic cancer, such as gemcitabine and fluorouracil [48][49][50][51].…”
Section: Temperature Measurementsmentioning
confidence: 99%
“…The most wellinvestigated and well-known physiological effects of hyperthermia are the increase in local blood flow and the alterations in vascular permeability, and the change in tumour microenvironment [14,15]. Another physiological effect of hyperthermia that has recently gained more attention is the activation of the immune response by heat [16,17].…”
Section: Introductionmentioning
confidence: 99%
“…Hyperthermia sensitises tumour cells to radiation and chemotherapy by altering tumour biology, both at the physiological and molecular level [13,14]. The most wellinvestigated and well-known physiological effects of hyperthermia are the increase in local blood flow and the alterations in vascular permeability, and the change in tumour microenvironment [14,15].…”
Section: Introductionmentioning
confidence: 99%
“…Several lines of evidence show that factors involved in DSB repair are likely to be affected by heat shock, for example, Ku heterodimer (Ku70/Ku80) [33][34][35][36], MRN complex [37][38][39], breast cancer susceptibility gene 1 (BRCA1) [40], BRCA2 [41] and RAD51 [41,42]. Heat shock affects these proteins by causing denaturation, cytoplasmic translocation from the nucleus, and protein degradation by the proteasome pathway [43]. These biological observations are currently proposed as possible reasons why IR combined with heat shock results in increased cell death with excessive unrepaired DSBs compared with IR alone [44].…”
Section: Discussionmentioning
confidence: 99%